Genetic Signatures is developing and commercialising a platform technology called 3Base which is applicable to all specimen types, and compatible with DNA, RNA and nucleic acid detection technology. The company’s lead product offering is the EasyScreen series of tests, used for rapidly detecting infectious diseases. The polymerase chain reaction-based products are used in hospitals and pathology laboratories in regions across the world, including in Australia and New Zealand, Israel and Europe, the US and North America and other nations.
Meet Great Boulder Resources Ltd, Mainstream Group Holdings Ltd, Blackstone Minerals Ltd, Pacific American Coal Ltd and Reward Minerals Ltd at our event, Sydney , 19 November 2018. Register here »